About ERLONAT ERLOTINIB TABLETS
Erlonat Tablets
Erlonat contains erlotinib and belongs to a class of medications called kinase inhibitors. Erlonat is used for the treatment of non-small cell lung cancer. Erlonat is used in combination with gemcitabine for the treatment of pancreatic cancer that has spread to nearby tissues or to other parts of the body. The Erlotinib hydrochloride Tablets offered by us are also known as Erlonat...
Available as: 25 mg, 100 mg & 150 mg Tablets
Manufactured By: NATCO
Technical specification
- Product Name:Erlonat
- Contains:Erlotinib hydrochloride
- Form:Tablet
- Strength:25 mg, 100 mg & 150 mg
- Packing:Pack Of 30 Tablets
NOTE :- Erlonat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug...........
Benefits of ERLONAT Erlotinib TabletsERLONAT provides targeted therapy for non-small cell lung cancer and pancreatic cancer. Its oral formulation makes administration convenient for patients, and the medication is recognized for its efficacy in managing advanced stages of these cancers by inhibiting specific cancer cell growth pathways. The blister strip packaging maintains the integrity of each tablet.
Proper Usage and Dosage MeasuresERLONAT tablets should be taken orally as directed by a qualified healthcare professional. Dosage strength is available in 100 mg and 150 mg options and should be determined based on individual medical assessment. It is crucial to follow prescription guidelines and not self-adjust dosage without medical consultation to ensure treatment safety and efficacy.
Packaging and Storage RecommendationsSupplied in blister strips within boxes containing 30 tablets each, ERLONATs packaging protects the product from moisture and contamination. Store the tablets in a cool, dry environment and ensure they are kept out of reach of children. Proper storage is vital to maintaining potency throughout the 36-month shelf life.
FAQs of ERLONAT ERLOTINIB TABLETS:
Q: How should ERLONAT Erlotinib Tablets be taken for maximum effectiveness?
A: The tablets should be administered orally exactly as prescribed by a healthcare provider, typically once daily. It is advisable to take them on an empty stomach, at least one hour before or two hours after a meal, unless otherwise instructed by your doctor.
Q: What is the primary indication for ERLONAT Erlotinib Tablets?
A: ERLONAT is primarily indicated for the treatment of non-small cell lung cancer and pancreatic cancer, usually in cases where the disease is advanced or metastatic.
Q: When is a valid prescription required to obtain ERLONAT Erlotinib Tablets?
A: A valid medical prescription is required at all times to purchase ERLONAT, as it is a regulated anticancer medication intended only for patients under professional medical supervision.
Q: Where is ERLONAT Erlotinib Tablets manufactured and distributed?
A: ERLONAT tablets are manufactured and marketed by Natco Pharma Ltd. in India and distributed by authorized exporters, suppliers, traders, and wholesalers throughout the country and internationally.
Q: What are the packaging specifications of ERLONAT Erlotinib Tablets?
A: Each box contains 30 tablets packed in blister strips, which help preserve the tablets quality and prevent exposure to environmental contaminants. The tablets are white to off-white and odorless.
Q: How should ERLONAT Erlotinib Tablets be stored to maintain their quality?
A: Store ERLONAT tablets in a cool, dry place away from direct sunlight and moisture. Proper storage extends the shelf life to 36 months and protects the medications efficacy.
Q: What benefits can patients expect from taking ERLONAT Erlotinib Tablets?
A: Patients can benefit from ERLONATs targeted action against cancer cell growth in non-small cell lung cancer and pancreatic cancer, potentially improving disease management and quality of life.